ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

HHS To Award “Micro-Grants” For Public Health Programs.

July 20, 2001

Antman Is President Elect; Minorities More Likely To Get Worse Care, IOM Finds

April 12, 2002

President Accepts Compromise On HEW Money Bill; Cancer Gets $523.6 Million

December 21, 1973

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

In Brief: NIH AIDS William Paul To Step down; Aldige to Lead NCCR; Rimer Joins NCI

October 10, 1997

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978